Greenwood Capital Associates LLC Chembio Diagnostics, Inc. Transaction History

Greenwood Capital Associates LLC

  • $745 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021
SELL
$4.11 - $7.51 $79,425 - $145,130
-19,325 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$3.28 - $5.93 $125,712 - $227,279
-38,327 Reduced 66.48%
19,325 $94,000
Q2 2020

Aug 12, 2020
BUY
$3.18 - $15.54 $183,333 - $895,912
57,652 New
57,652 $187,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email